About
Cardiovalve develops transcatheter implantable replacement heart valves for treating mitral and tricuspid valve diseases using minimally invasive catheter-based technology, designed to be delivered transfemorally to avoid open heart surgery.
Explore Cardiovalve's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.